Cargando…

GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells

Differentiation therapy provides an alternative treatment of cancer that overcomes the undesirable effects of classical chemotherapy, i.e. cytotoxicity and resistance to drugs. This new approach to cancer therapy focuses on the development of specific agents designed to selectively engage the proces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marchal, J A, Prados, J, Melguizo, C, Gómez, J A, Campos, J, Gallo, M A, Espinosa, A, Arena, N, Aránega, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362655/ https://www.ncbi.nlm.nih.gov/pubmed/10070873 http://dx.doi.org/10.1038/sj.bjc.6690129

Ejemplares similares

Modulation of Myogenic Differentiation in a Human Rhabdomyosarcoma Cell Line by a New Derivative of 5‐Fluorouracil (QF‐3602)
por: Marchal, Juan Antonio, et al.
Publicado: (2000)

Multidrug Resistance Phenotype in the RMS‐GR Human Rhabdomyosarcoma Cell Line Obtained after Polychemotherapy
por: Prados, Jose, et al.
Publicado: (1999)

Characterization of a New Human Embryonal Rhabdomyosarcoma Cell Line, RMS‐GR
por: Fernández, Juan Emilio, et al.
Publicado: (1998)

Acyclonucleosides: Part 2. diseco-Nucleosides
por: El Ashry, E.S.H., et al.
Publicado: (1997)

Carboxylated Acyclonucleosides: Synthesis and RNase A Inhibition
por: Chakraborty, Kaustav, et al.
Publicado: (2015)

Inhibition of growth and induction of apoptosis in human breast cancer by transfection of gef gene
por: Boulaiz, H, et al.
Publicado: (2003)

Synthesis of (R)- and (S)-β-hydroxyphosphonate acyclonucleosides: structural analogues of Adefovir (PMEA)
por: Kasthuri, Mahesh, et al.
Publicado: (2011)

5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
por: Ortiz, Raúl, et al.
Publicado: (2012)

Nanomedicine: Application Areas and Development Prospects
por: Boulaiz, Houria, et al.
Publicado: (2011)

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
por: Chau, I, et al.
Publicado: (2001)

The Chemotherapeutic Drug 5-Fluorouracil Promotes PKR-Mediated Apoptosis in a p53- Independent Manner in Colon and Breast Cancer Cells
por: García, María Angel, et al.
Publicado: (2011)

Synthesis of New 1,2,3-Triazol-4-yl-quinazoline Nucleoside and Acyclonucleoside Analogues
por: Ouahrouch, Abdelaaziz, et al.
Publicado: (2014)

PDEPT: polymer-directed enzyme prodrug therapy
por: Satchi, R, et al.
Publicado: (2001)

891. Epidemiology and Outcomes of Sepsis in Previously Healthy Patients
por: Alrawashdeh, Mohammad, et al.
Publicado: (2019)

Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
por: Anderson, J, et al.
Publicado: (2001)

gef Gene Expression in MCF-7 Breast Cancer Cells is Associated with a Better Prognosis and Induction of Apoptosis by p53-Mediated Signaling Pathway
por: Boulaiz, Houria, et al.
Publicado: (2011)

Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines
por: Cocker, H A, et al.
Publicado: (2000)

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial
por: Waters, J S, et al.
Publicado: (1999)

POS-891 HEMODIALYSIS PATIENTS WITH SEVERE COVID-19: REDUCED ANTIBODY RESPONSE
por: BEPPU, H., et al.
Publicado: (2022)

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer
por: Sobrero, A, et al.
Publicado: (2001)

An Oral Fluorouracil Prodrug, Capecitabine, Mitigates a Gram-Positive Systemic Infection in Mice
por: McLeod, Jack R., et al.
Publicado: (2021)

Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material
por: Webley, S D, et al.
Publicado: (2001)

Molecular features of a human rhabdomyosarcoma cell line with spontaneous metastatic progression
por: Scholl, F A, et al.
Publicado: (2000)

Synthesis, Structural Characterization, and Biological Activity of New Pyrazolo[4,3-e][1,2,4]triazine Acyclonucleosides
por: Mojzych, Mariusz, et al.
Publicado: (2020)

Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin
por: Platel, D, et al.
Publicado: (1999)

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
por: Grosios, K, et al.
Publicado: (1999)

Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)
por: Monks, N R, et al.
Publicado: (2000)

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
por: Kornek, G V, et al.
Publicado: (2000)

A randomized phase II trial of 5-fluorouracil, with or without human interferon-β, for advanced colorectal cancer
por: Villar-Grimalt, A, et al.
Publicado: (1999)

Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil
por: Palmer, D H, et al.
Publicado: (2003)

Expressions of Hippocampal Mineralocorticoid Receptor (MR) and Glucocorticoid Receptor (GR) in the Single-Prolonged Stress-Rats
por: Zhe, Du, et al.
Publicado: (2008)

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines
por: Fischel, J-L, et al.
Publicado: (2001)

Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure
por: Melguizo, Consolación, et al.
Publicado: (2012)

Hematopoietic mosaic chromosomal alterations and risk for infection among 767,891 individuals without blood cancer
por: Zekavat, Seyedeh M., et al.
Publicado: (2020)

Increased cytotoxicity and bystander effect of 5-fluorouracil and 5′-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase
por: Evrard, A, et al.
Publicado: (1999)

Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug
por: Cheng, T L, et al.
Publicado: (1999)

Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?
por: Humphrey, G, et al.
Publicado: (1999)

Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha
por: Braybrooke, J P, et al.
Publicado: (2000)

GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life
por: Louw, Ann
Publicado: (2019)

High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance
por: Cocker, H A, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_2dqsafumcu8nhcfs034ircku1b